Goodbye, needles? Patch might be the future for blood-sugar tracking

January 4, 2018 by Serena Gordon, Healthday Reporter

(HealthDay)—Developers of a new patch hope to eliminate a big barrier in type 2 diabetes treatment—painful finger-sticks and injections.
The new patch—which actually uses an array of tiny needles that researchers promise are pain-free—senses when blood sugar levels are rising and then releases medication to bring those elevated levels back down.

That means the could end the need to draw blood from your fingertips to check your . It could also eliminate the needles used to administer insulin or other diabetes medications.

"This type of disposable patch is expected to control for a week," said the study's senior author, Xiaoyuan (Shawn) Chen, chief of the laboratory of molecular imaging and nanomedicine at the U.S. National Institute of Biomedical Imaging and Bioengineering in Bethesda, Md.

"It will not complicate the routines of daily living," Chen said.

Though the patch looks promising, so far it's been tested only on 21 mice with type 2 diabetes. Results from animal trials aren't always equaled in human trials.

The patch contains chemicals that sense rising blood sugar levels. When that happens, a medication called exendin-4 is released to trigger the body to produce insulin until blood sugar levels start to fall.

Exendin-4 is part of a class of drugs called GLP-1 receptor agonists. It's currently on the market in the United States as Byetta, a twice-daily injection. Other drugs in this class of injectable medications include Trulicity and Bydureon, which are weekly injections, and Victoza, which is a daily injection, according to the American Diabetes Association.

For the patch, exendin-4 is combined with alginate, a gum-like material extracted from brown algae. This mixture is then poured into microneedle form and loaded onto the patch.

The patch tested on the mice was about a half-inch square, according to the researchers. It contained enough medication for a week.

"We achieved a smart, long-acting and glucose-responsive exendin-4 release," Chen said.

He noted that some of the mice had inflammation at the site of the patch. In humans, nausea and vomiting are known side effects of the drug, but the researchers believe that the release of exendin-4 is slow enough that it won't cause those side effects.

The next step is to make a larger patch with more needles, Chen explained. The researchers will also need to create longer needles to penetrate human skin.

Dr. Joel Zonszein, director of the Clinical Diabetes Center at Montefiore Medical Center in New York City, said it looked like the patch worked well in the study.

"But it's a big stretch from mice to even trying something like this in humans and getting approved by the [U.S. Food and Drug Administration]," said Zonszein, who wasn't involved with the study.

Still, he said, the patch itself is a very good idea, and the beauty of it would be that it wouldn't require people with diabetes to spend a lot of time managing their disease.

However, Zonszein pointed out that oral versions of GLP-1 drugs are in clinical trials and will compete with injections in the not-far-off future.

Also, while the patch idea is interesting, "exendin-4 is the wrong medication," Zonszein said. If researchers could figure out how to make the patch with insulin, he said, that would likely be a better option, though the required doses of insulin might be too large to fit in the patch.

Results of the researchers' study on the patch treatment on mice were published online recently in Nature Communications.

Explore further: ​New patch aims to turn energy-storing fats into energy-burning fats

More information: Xiaoyuan (Shawn) Chen, Ph.D., chief, laboratory of molecular imaging and nanomedicine, U.S. National Institute of Biomedical Imaging and Bioengineering, Bethesda, Md.; Joel Zonszein, M.D., director, Clinical Diabetes Center, Montefiore Medical Center, New York City; Nature Communications, Nov. 24, 2017, online

The American Diabetes Association has more on treating type 2 diabetes.

Related Stories

​New patch aims to turn energy-storing fats into energy-burning fats

December 28, 2017
A micro-needle patch delivers drugs that are known to turn energy-storing white fat into energy-burning brown fat. This innovative approach developed by scientists from Nanyang Technological University, Singapore (NTU Singapore), ...

A glucose testing patch that doesn't require pricking the skin

December 21, 2017
A team of researchers from Tsinghua University working with People's Liberation Army Air Force General Hospital, both in China, has developed a two-stage patch that can be used to test glucose levels. In their paper published ...

Researchers design synthetic beta cells to secrete insulin in response to high blood sugar

October 30, 2017
Treating type 1 diabetes and some cases of type 2 diabetes has long required painful and frequent insulin injections or a mechanical insulin pump for insulin infusion. But researchers from the University of North Carolina ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Thirty-year study shows women who breastfeed for six months or more reduce their diabetes risk

January 16, 2018
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.